JPMorgan Chase & Co. Has $993,000 Stock Position in Definitive Healthcare Corp. (NASDAQ:DH)

JPMorgan Chase & Co. increased its stake in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 431.7% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 222,090 shares of the company's stock after acquiring an additional 180,323 shares during the period. JPMorgan Chase & Co. owned approximately 0.19% of Definitive Healthcare worth $993,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Millennium Management LLC acquired a new position in shares of Definitive Healthcare in the 2nd quarter worth approximately $9,283,000. Massachusetts Financial Services Co. MA boosted its holdings in Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company's stock worth $27,058,000 after buying an additional 1,626,813 shares in the last quarter. 272 Capital LP boosted its holdings in Definitive Healthcare by 74.8% during the third quarter. 272 Capital LP now owns 1,114,080 shares of the company's stock worth $4,980,000 after buying an additional 476,766 shares in the last quarter. State Street Corp increased its holdings in shares of Definitive Healthcare by 29.4% in the third quarter. State Street Corp now owns 1,399,729 shares of the company's stock valued at $6,257,000 after buying an additional 317,952 shares in the last quarter. Finally, Marshall Wace LLP acquired a new stake in shares of Definitive Healthcare during the 2nd quarter valued at $1,535,000. Institutional investors and hedge funds own 98.67% of the company's stock.

Analysts Set New Price Targets

Several research analysts have commented on DH shares. Barclays reiterated an "underweight" rating and issued a $4.00 target price on shares of Definitive Healthcare in a report on Monday, January 13th. Stephens initiated coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They set an "equal weight" rating and a $5.00 price objective on the stock. Finally, Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a research note on Thursday, January 16th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Definitive Healthcare currently has a consensus rating of "Hold" and an average price target of $5.72.

Definitive Healthcare Stock Performance

Shares of Definitive Healthcare stock traded down $0.04 during trading on Friday, reaching $4.83. The company's stock had a trading volume of 569,336 shares, compared to its average volume of 617,054. Definitive Healthcare Corp. has a one year low of $3.19 and a one year high of $10.62. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The firm has a market cap of $557.96 million, a price-to-earnings ratio of -1.56, a price-to-earnings-growth ratio of 3.54 and a beta of 1.41. The business's fifty day moving average price is $4.36 and its 200-day moving average price is $4.46.

Definitive Healthcare (NASDAQ:DH - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.03). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The company had revenue of $62.70 million during the quarter, compared to analyst estimates of $61.66 million. During the same quarter in the previous year, the business posted $0.01 EPS. As a group, equities research analysts predict that Definitive Healthcare Corp. will post 0.15 earnings per share for the current year.

Insider Activity

In related news, insider William Moschella sold 45,000 shares of the stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares of the company's stock, valued at $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 14.84% of the stock is currently owned by company insiders.

Definitive Healthcare Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.